PRODUCTS

ColoDefense® Multiplex Blood DNA Methylation Test Kit for Colorectal Cancer

This kit detects the presence of multiple DNA methylation biomarkers in a patient’s blood by highly sensitive fluorescent quantitative PCR technique to determine the patient’s risk for colorectal tumor.

  • Product Description

    Product features

    1. It can be used for early screening of colorectal cancer, auxiliary diagnosis, and prognosis of postoperative recurrence.
    2. It achieves high sensitivity and specificity through the combination of bioinformatics-based system thermodynamics guided design and simultaneous detection of multiple methylation biomarkers.
    3. It features non-invasive detection and high public acceptance compared to colonoscopy.
    4. It features an easy and fast procedure with low cost;
    5. It can detect advanced adenomas and early CRCs better than other commercially available blood based test products.

    Technical performance indicators

    Test results of more than 1,000 clinical samples show the following:

    1. The sensitivities of this kit for the detection of stage I colorectal cancer, stage I-IV colorectal cancer and advanced adenomas are 74%, 88% and 45%, respectively.
    2. Its specificity stands at 93%.

     

     Note: This kit is for research use only, but not for clinical diagnosis.